iAnn: an event sharing platform for the life sciences

Summary: We present iAnn, an open source community-driven platform for dissemination of life science events, such as courses, conferences and workshops. iAnn allows automatic visualisation and integration of customised event reports. A central repository lies at the core of the platform: curators add submitted events, and these are subsequently accessed via web services. Thus, once an iAnn widget is incorporated into a website, it permanently shows timely relevant information as if it were native to the remote site. At the same time, announcements submitted to the repository are automatically disseminated to all portals that query the system. To facilitate the visualization of announcements, iAnn provides powerful filtering options and views, integrated in Google Maps and Google Calendar. All iAnn widgets are freely available. Availability: http://iann.pro/iannviewer Contact: [email protected]

Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

Genetic influences on psychiatric disorders transcend diagnostic boundaries, suggesting substantial pleiotropy of contributing loci. However, the nature and mechanisms of these pleiotropic effects remain unclear. We performed analyses of 232,964 cases and 494,162 controls from genome-wide studies of anorexia nervosa, attention-deficit/hyper-activity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, and Tourette syndrome. Genetic correlation analyses revealed a meaningful structure within the eight disorders, identifying three groups of inter-related disorders. Meta-analysis across these eight disorders detected 109 loci associated with at least two psychiatric disorders, including 23 loci with pleiotropic effects on four or more disorders and 11 loci with antagonistic effects on multiple disorders. The pleiotropic loci are located within genes that show heightened expression in the brain throughout the lifespan, beginning prenatally in the second trimester, and play prominent roles in neurodevelopmental processes. These findings have important implications for psychiatric nosology, drug development, and risk prediction.Peer reviewe

Can functional traits predict ecological interactions? A case study using rain forest frugivores and plants in Australia

In rain forest, the large numbers of species of fleshy-fruited plants and frugivorous animals result in a large number of potential fruit–frugivore interactions, which are challenging to survey in the field. Yet, knowledge of these relationships is needed to predict consequences of changes in the frugivore assemblage for seed dispersal. In the absence of comprehensive dietary information, it may be possible to delineate between frugivores that disperse different plants using 'functional traits,' or morphological and behavioral attributes of frugivores that interact with differences in salient characteristics of plant species. Here we use data on the consumption of 244 Australian rain forest plant species by 38 bird species to test for associations between patterns of frugivory and birds': (1) degree of frugivory, (2) gape width, and (3) seed treatment (seed crushing or seed dispersing). Degree of frugivory and gape width explain 74 percent of the variation in the sizes of fruits consumed by frugivorous birds. Among birds that consume a substantial dietary proportion of fruit, birds with wider gapes consume larger fruits. In contrast, this relationship was not shown by birds for which fruit is only a minor dietary component. Degree of frugivory and gape width, together with seed treatment, also strongly predict the overall taxonomic composition and diversity of plants consumed by bird species. Functional classifications of frugivore species may prove useful in developing a predictive understanding of fruit–frugivore interactions in other rain forest regions where detailed dietary information is not available for most frugivores

Reduced dispersal of native plant species as a consequence of the reduced abundance of frugivore species in fragmented rainforest

Frugivorous animals disperse the seeds of the majority of rainforest plant species and hence play a key role in the trajectory of rainforest regeneration. This study investigated whether changes in the species composition of the frugivore community in fragmented rainforest in subtropical Australia is likely to impact the dispersal of native plant species. The potential of frugivorous bird and bat species to disperse the seeds of plant species in fragmented rainforest was assessed using published dietary information together with field surveys of frugivore abundance within intact forest, forest fragments and patches of regrowth. Frugivore species with reduced abundance in fragmented rainforest were the only known dispersers of 27 of the 221 native plant species in the data set (12% of species). These frugivore species were also major dispersers of plant species producing fruits wider than 10 mm and species from the families Rubiaceae, Lauraceae, Myrtaceae, Meliaceae, Lamiaceae and Vitaceae. Except for Rubiaceae, these plant taxa are also potentially dispersed by two of the frugivore species that were widespread in fragmented rainforest, Lopholaimus antarcticus and Ptilonorhynchus violaceus, although dispersal rates are likely to be lower in fragmented than in extensive rainforest. Consistent with other regions, large-seeded plants are susceptible to reduced dispersal in fragmented rainforest in subtropical Australia. However, we predict a smaller deficit in seed dispersal in fragmented forests than has been reported from other regions, due to factors such as functional overlap among frugivore species, the ability of many Australian rainforest vertebrates to persist in fragmented rainforest, and a lack of hunting in these forests. Nevertheless, rainforest fragmentation has reduced the abundance of a suite of frugivorous rainforest fauna, which in turn is likely to reduce the dispersal of a certain plant taxa and may alter patterns of plant regeneration in subtropical Australian rainforest fragments

Biodiversity: adaptation pathways and opportunities

The possibilities, issues and barriers pertaining to the adaptation of biodiversity to climate change show similarities across the different ecosystem types, species and processes of the Wet Tropics Cluster (WTC) region. Many management actions for climate change are the same as those already known to be important to biodiversity management: reduce or eliminate other anthropogenic stressors in order to build integrity and resilience into natural systems and ideally assist them to withstand the future pressures associated with climate change. However, climate change will also involve different approaches in many respects including facilitating change, especially the movement of species and ecosystems as they track suitable climate and conditions. In addition, 'in situ' conservation – managing species in their habitat, or facilitating their dispersal within the landscape - will be less expensive than 'ex situ' conservation (managing species outside their current range)

Empagliflozin in Patients with Chronic Kidney Disease

Background The effects of empagliflozin in patients with chronic kidney disease who are at risk for disease progression are not well understood. The EMPA-KIDNEY trial was designed to assess the effects of treatment with empagliflozin in a broad range of such patients. Methods We enrolled patients with chronic kidney disease who had an estimated glomerular filtration rate (eGFR) of at least 20 but less than 45 ml per minute per 1.73 m(2) of body-surface area, or who had an eGFR of at least 45 but less than 90 ml per minute per 1.73 m(2) with a urinary albumin-to-creatinine ratio (with albumin measured in milligrams and creatinine measured in grams) of at least 200. Patients were randomly assigned to receive empagliflozin (10 mg once daily) or matching placebo. The primary outcome was a composite of progression of kidney disease (defined as end-stage kidney disease, a sustained decrease in eGFR to < 10 ml per minute per 1.73 m(2), a sustained decrease in eGFR of & GE;40% from baseline, or death from renal causes) or death from cardiovascular causes. Results A total of 6609 patients underwent randomization. During a median of 2.0 years of follow-up, progression of kidney disease or death from cardiovascular causes occurred in 432 of 3304 patients (13.1%) in the empagliflozin group and in 558 of 3305 patients (16.9%) in the placebo group (hazard ratio, 0.72; 95% confidence interval [CI], 0.64 to 0.82; P < 0.001). Results were consistent among patients with or without diabetes and across subgroups defined according to eGFR ranges. The rate of hospitalization from any cause was lower in the empagliflozin group than in the placebo group (hazard ratio, 0.86; 95% CI, 0.78 to 0.95; P=0.003), but there were no significant between-group differences with respect to the composite outcome of hospitalization for heart failure or death from cardiovascular causes (which occurred in 4.0% in the empagliflozin group and 4.6% in the placebo group) or death from any cause (in 4.5% and 5.1%, respectively). The rates of serious adverse events were similar in the two groups. Conclusions Among a wide range of patients with chronic kidney disease who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from cardiovascular causes than placebo